Display Settings:

Format

Send to:

Choose Destination

    Clin Infect Dis. 2000 Mar;30(3):466-72.

    Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.

    Garbutt JM, Ventrapragada M, Littenberg B, Mundy LM.

    Division of General Medical Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA. garbutt@osler.wustl.edu

    Comment in:

    We conducted a retrospective cohort study to determine the association between resistance to vancomycin and mortality among hospitalized patients with Enterococcus faecium bacteremia. We compared outcomes for patients infected with vancomycin-resistant versus vancomycin-susceptible E. faecium among 69 patients with bacteremia defined according to the National Nosocomial Infections Surveillance system. The univariate odds ratio (OR) for death associated with vancomycin resistance was 2.1 (P=.172). After controlling for severity of illness, we found that vancomycin resistance was not associated with mortality (OR, 1.74; 95% confidence interval, 0.5-6.12; P=.39). Vancomycin resistance does not independently increase mortality among patients with E. faecium bacteremia.

    PMID: 10722429 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information

    • Vancomycin (Vancocin®)

      Vancomycin is used to treat colitis (inflammation of the intestine caused by certain bacteria) that may occur after antibiotic treatment. Vancomycin is in a class of medications called glycopeptide antibiotics. It works ...